Clinical Trial Update: Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Globo H-KLH immunotherapy in women with non-progressive ovarian cancer; the current status of the study is not reported in the record.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Globo H-KLH (OPT-822/821)

Snippet

Sponsor: Mackay Memorial Hospital | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN